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Outbreak of Shewanella algae and Shewanella putrefaciens
Infections Caused by a Shared Measuring Cup
in a General Surgery Unit in Korea
Hyang Soon Oh, RN, MPH, CIC, PhD; Kyung Ah Kum, RN, MPH; Eui-Chong Kim, MD; Hoan-Jong Lee, MD;
Kang Won Choe, MD; Myoung Don Oh, MD
objective. To control an outbreak of Shewanella algae and S. putrefaciens infections by identifying the risk factors for infection and
transmission.
design. Matched case-control study.
setting. A university-affiliated tertiary acute care hospital in Seoul, Republic of Korea, with approximately 1,600 beds.
patients. From June 20, 2003, to January 16, 2004, a total of 31 case patients with Shewanella colonization or infection and 62 control
patients were enrolled in the study.
interventions. Requirement to use single-use measuring cups and standard precautions (including hand washing before and after patient
care and use of gloves).
results. S. algae or S. putrefaciens was isolated from blood, for 9 (29.0%) of 31 patients who acquired one of the organisms; from bile,
for 8 (25.8%), and from ascitic fluid, for 8 (25.8%). The attack rate of this outbreak was 5.8% (31 patients infected or colonized, of 534
potentially exposed on ward A) and the pathogenicity of the two species together was 77.4% (24 patients infected, of 31 who acquired the
pathogens). The estimated incubation period for Shewanella acquisition was 3– 49 days. Using logistic analysis, we identified the following
risk factors: presence of external drainage catheters in the hepatobiliary system (odds ratio [OR], 20; P  .001), presence of hepatobiliary
disease (OR, 6.4; P  .001), admission to the emergency department of the hospital (OR, 2.9; P  .039), wound classification of
“contaminated” or “dirty or infected” (OR, 16.5; P  .012), an American Society of Anesthesiologists score of 3 or higher (OR, 8.0; P 
.006), duration of stay in ward A (OR, 1.1; P  .001), and, for women, an age of 60 – 69 years (OR, 13.3; P  .028). A Shewanella isolate
was recovered from the surface of a shared measuring cup, and 12 isolates of S. algae showed the same pulsed-field gel electrophoresis
pattern.
conclusions. This Shewanella outbreak had a single-source origin and spread by contact transmission via a contaminated measuring cup.
Shewanella species are emerging as potentially serious human pathogens in hospitals and could be included in hospital infection surveillance
systems.
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uly 1The natural habitats of Shewanella species are water (including
fresh, brackish, and salt) and soil; they have also been isolated
from marine environments, sediments, and oil fields.1-7 The first
report of Shewanella acquisition by humans was in 1964,8 and
there was no report of humans being infected with Shewanella until
1975.9 Since then, more than 40 reports or reviews concerning
Shewanella infection in humans have been published (according to a
search of Medline). Shewanella algae and Shewanella putrefaciens are
associated with human infections that include bacteremia,6,10-22 cellu-
litis (skin and soft tissue infection),6,9,10,14-16,23-27 ear infection,28,29 cere-
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outbreak of shewanella infections 743No Shewanella infections in humans or clinical isolates of
this pathogen had been reported in the Republic of Korea be-
fore June 2003. Between June 20, 2003, and January 16, 2004, a
total of 31 cases of S. algae or S. putrefaciens infection or colo-
nization were identified; they were clustered in a single general
surgical ward of Seoul National University Hospital. In this
study, we report the results of an investigation of this epidemic.
The aims of this study were to describe the epidemiological
features of Shewanella infection and to identify the modes of
transmission and the risk factors for acquisition, so that the
infections can be controlled in the hospital.
methods
Settings
The study hospital is a university-affiliated tertiary acute care
hospital in Seoul, Republic of Korea, with approximately 1,600
beds. There are 5 general surgery wards for inpatients. The
outbreak of S. algae and S. putrefaciens occurred in a single
general surgery ward, ward A, which has 34 beds, 11 registered
nurses, 2 nurse aides, and 3 physicians (2 resident physicians
and 1 intern). Surgeons, who were professorial staff, attended
to patients and performed surgery in their specialty areas in the
5 general surgery wards. The patients were randomly admitted
to any of the 5 general surgery wards, regardless of diagnosis,
severity of disease, or other considerations.
Case Definition and Case Ascertainment
Case patients were defined as patients on ward A who had S.
algae or S. putrefaciens isolated from any clinical specimens
from June 20, 2003, to January 16, 2004. Both S. algae and S.
putrefaciens were included because they are biologically simi-
lar, and S. algae has only recently been reclassified to distin-
guish it from S. putrefaciens.1 A total of 31 case patients were
enrolled in the study. Case patients were categorized as in-
fected or colonized with Shewanella according to the defini-
tions of the Centers for Disease Control and Prevention.37,38
We identified case patients by microbiologic surveillance.
Epidemiologic Investigation and Statistical Analysis
A retrospective, matched case-control study was performed. A
total of 62 control patients were selected from ward A to be
matched at a ratio of 2:1 by month of admission, to control for
exposure time during the epidemic period. These control pa-
tients were randomly selected using SPSS for Windows, ver-
sion 12.0 (SPSS). Patient data were collected on age, sex, un-
derlying disease, duration of hospital stay, history of smoking
and drinking, type of hospital admission, type of surgery per-
formed, receipt of other invasive treatments, and type of sur-
gical drain used.
Data distributions were checked using data exploration
methods and then initially analyzed using descriptive statistics
(frequency distribution, the Student t test, and the 2 test).
Univariate analysis was done with a general linear model andunivariate logistic methods, and multivariate logistic analysis
(ie, forward stepwise conditional logistic regression analysis)
was also done. Odds ratios (ORs) were used to identify the risk
factors for the acquisition of S. algae or S. putrefaciens. Statis-
tical analyses were performed using SPSS for Windows, ver-
sion 12.0 (SPSS). A P value of less than .05 was considered
statistically significant.
Procedure and Observational Reviews
We closely observed the following infection control practices
of healthcare workers (HCWs): use of aseptic technique for an
entire operative procedure, for angiographic procedures, and
for postoperative wound and drain care; use of saline solution;
disinfection and sterilization of devices; hand hygiene; and use
of gloves before and after caring for a patient’s wound. We
reviewed any changes in patient care: use of commercial nor-
mal saline, invasive devices, and other materials; the skills and
practices of HCWs; and the staff-to-patient ratio.
Microbiological Studies
We performed an extensive environmental investigation be-
cause of the wide range of natural habitats and halophilicity of
Shewanella species.1,3 The water sources investigated included
the normal saline solution used in intravenous infusions,
wound irrigation, and drainage catheter flushing or irrigation;
distilled water used in large room air humidifiers, sink water,
and diluted antiseptics; water and soil in flowerpots in the
nursing station; and any food preserved with salt or raw sea-
food supplied by the patients’ families. The following patient-
care devices were also included in the investigation: the sur-
faces of stainless steel dressing carts and the blood-pressure
cuffs, stethoscopes, and thermometers that are commonly
shared among patients.
Clinical specimens submitted for bacterial culture were an-
alyzed with standard microbiologic procedures. Environmen-
tal samples were inoculated onto MacConkey agar plates, and
colorless colonies were selected after overnight incubation.
The isolates were identified with the Vitek 2 automated system
(boiMérieux).
Pulsed-Field Gel Electrophoresis (PFGE)
PFGE was performed according to the modified procedures of
PulseNet.39 In brief, agarose-embedded DNA was digested
with 40 U of SmaI (New England Biolabs) for 4 hours at 25°C.
The restriction fragments were separated by electrophoresis in
a 0.5  Tris-borate-ethylenediaminetetraacetic acid buffer at
14°C for 15 hours using a CHEF Mapper electrophoresis sys-
tem (Bio-Rad) with pulse times of 5.16 – 40.17 seconds. The
gels were stained with ethidium bromide, and DNA bands
were visualized with UV transillumination.
Infection Control Procedures
After this outbreak, single-use measuring cups were used, and
standard precautions for HCWs included hand hygiene before
h Sh
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nique was also required.
results
Case Patients
From June 20, 2003, to January 16, 2004, a total of 31 case
patients with S. algae or S. putrefaciens infection or coloniza-
tion were identified (Figure 1). There were 2 possible index
patients. One was a 63-year-old woman with a Klatskin tumor,
who was admitted to the emergency department with ascend-
ing cholangitis on June 20, 2003. She had had recurring epi-
sodes of common bile duct stones since 1991, when she had
undergone a cholecystectomy and choledochostomy for com-
mon bile duct stones. S. putrefaciens and Aeromonas hydrophila
were first isolated from culture of her external percutaneous
transhepatic biliary drainage catheter on June 29, 2003. The
other possible index patient was a 66-year-old woman with
hepatocellular carcinoma, who was admitted on June 26, 2003;
S. algae was first isolated from culture of her Jackson-Pratt
catheter on July 9, 2003.
S. algae was isolated from 25 case patients, and S. putrefaciens
was isolated from 6 case patients; both species were not isolated
from any single case patient. S. algae and S. putrefaciens were iso-
lated from blood, for 9 patients (29.0%, 8 with S. algae and 1 with
figure 1. Epidemic curve for the outbreak of infection wit
figure 2. Monthly attack rate of infection or colonization with
potentially exposed.S. putrefaciens); from bile, for 8 (25.8%, 7 with S. algae and 1 with
S. putrefaciens); from ascitic fluid, for 8 (25.8%, 5 with S. algae and
3 with S. putrefaciens); from skin and soft tissue, for 5 (16.1%, 4
with S. algae and 1 with S. putrefaciens); and from stool, for 1
(3.2%) with S. algae. Healthcare-acquired Shewanella infec-
tions developed in 24 (77%) of the 31 case patients (20 [64%]
with S. algae and 4 [13%] with S. putrefaciens).The remaining 7
(23%) case patients were colonized with either S. algae or S.
putrefaciens. Of the 24 case patients infected with Shewanella, 5
(21%) developed a bloodstream infection (all with S. algae),
and 19 (79%) developed a surgical site infection (15 [79%]
with S. algae and 4 [21%] with S. putrefaciens). Of the 19 cases
of surgical site infection, 13 (68%) were an intra-abdominal
infection with hepatobiliary tract infection, 4 (21%) were su-
perficial incisional wound infection, and 2 (11%) were deep
incisional wound infection.
Of the 31 case patients, 21 (67.7%) had hepatobiliary dis-
ease. All 31 case patients had external drainage catheters, 23
(74.2%) of whom had their catheters located in or near the
hepatobiliary system.
Case patients presented with the following signs and symp-
toms: fever (temperature, 38°C) in 23 patients (74.2%), ab-
dominal pain in 9 (29.0%), pus or purulent drainage in 9
(29.0%), and chills in 6 (19.4%). The mean interval ( SD)
ewanella algae or Shewanella putrefaciens (n  31), by month
wanella algae and Shewanella putrefaciens. There were 534 patientsShe
outbreak of shewanella infections 745from admission to ward A to isolation of Shewanella was 15.9
 10.1 days (range, 5–57 days), and the mean interval from
first drain insertion to isolation of Shewanella was 14.0  10.0
days (range, 3– 49 days).
Of the 31 case patients, 6 (19%) developed secondary sepsis:
5 (16%) with S. algae and 1 (3%) with S. putrefaciens (P  .99;
Fisher exact test). Of the 5 case patients who were infected with
S. algae, 3 (60%) died; the remaining 28 case patients recovered
from their infection.
Epidemiologic and Statistical Analysis
The attack rate of this outbreak of Shewanella infection was
5.8% (31 patients infected or colonized, of 534 potentially ex-
posed on the 5 study wards). The attack rate of for S. algae
table 1. Univariate Logistic Analysis (Forward Stepwise Conditio
and Shewanella putrefaciens






Mean age  SD, years
All patients 59.1  11.
Male patients 56.5  13.
Female patients 62.3  8.0
Age group, female patients
50 years 1 (7.1)
60–69 years 8 (57.1)
Tobacco use 3 (11.5)
Alcohol use 3 (11.5)
Clinical
Hepatobiliary disease 18 (58.1)
Admitted via emergency department 11 (35.5)
Duration of stay in ward A, mean  SD, days 29.5  20.3
Angiography 19 (61.3)
Surgery 28 (90.3)
Duration of procedure, minutes, mean  SD 224.5  110.
Wound classification
Clean 2 (6.5)
Clean contaminated 20 (64.5)




3 or 4 8 (25.8)
Drainage catheter remained in situ 31 (100.0)
Catheter located in the hepatobiliary system 20 (63.5)
Amount of external drainage fluid, mean 
SD, mL per day 151.1  181.
note. Data are no. (%) of patients or mean value SD, unless otherwise in
odds ratio.
a P value obtained by 2 test.
b P value obtained by t test.infection was 5.0% (25 patients infected or colonized, of 503potentially exposed), and the attack rate for S. putrefaciens in-
fection was 1.1% (6 patients infected or colonized, of 534 po-
tentially exposed) (Figure 2). The pathogenicity of the two spe-
cies together was 77.4% (24 patients developed infection, of 31
who acquired the pathogens); the pathogenicity of S. algae was
80% (20 of 25 patients), and that of S. putrefaciens was 66.7%
(4 of 6 patients) (Fisher’s exact test, P  .596).
In univariate analysis, we found that use of an external
drainage catheter was a significant risk factor (OR, 20; P 
.001) for acquisition of Shewanella species. The other risk
factors identified were as follows: presence of hepatobiliary
disease (OR, 6.4; P  .001), being female (OR, 13.3; P 
.01), hospital admission via the emergency department, a
surgical wound classification of “contaminated” or “dirty or
of Variables Possibly Associated With Acquisition of Shewanella algae
) Control patients (n  62) OR (95% CI) P
39 (63.0)
23 (37.0)
54.9  14.7 .166b
57.8  15.2 .759b
50.0  13.1 1.124 (1.029–1.220) .010
10 (43.5) 1.0
6 (26.1) 13.333 (1.321–134.615) .028
18 (29.5) .073a
26 (42.6) .003a
11 (17.7) 6.420 (2.443–16.870) .001
10 (6.1) 2.860 (1.052–7.772) .039
12.1  9.1 1.141 (1.073–1.214) .001
5 (8.1) 0.055 (0.017–0.178) .001
59 (96.7) .371a
144.7  85.2 1.008 (1.003–1.014) .001
1 (1.6) 1.0
46 (74.2)
2 (3.2) 16.500 (1.862–48.606) .012
24 (38.7) 1.0
26 (41.7)
4 (6.5) 8.000 (1.790–35.744) .006
36 (58.1) .001a
3 (8.3) 20.000 (4.971–80.473) .001
71.9  63.6 1.006 (1.001–1.012) .031






dicatinfected” (OR, 16.5), an American Society of Anesthesiolo-
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ward A (Table 1).
In multivariate logistic analysis with the variables hospital
stay in ward A, admission via the emergency unit, and hepato-
biliary disease, we found that the probability of acquisition of
Shewanella species was significantly influenced by the presence
of hepatobiliary disease and a hospital stay in ward A (Table 2).
Procedure and Observational Review
We did not find any lapses in the use of aseptic technique,
disinfection, and sterilization practices during operations or
angiographic procedures, or in use of salinity fluids. We did
not find any changes in use of commercial products or in the
staff-to-patient ratio. However, a measuring cup that was used
for catheter drainage was reused continuously for many pa-
tients. Strict “no-touch” technique was not maintained: when
a HCW drained a patient’s catheter bag, the bag’s opened port
easily touched the measuring cup. Hand hygiene and glove use
were not routinely practiced when HCWs cared for a patient’s
wound or external drainage catheter.
Microbiological Studies
There were 134 environmental specimens cultured. S. algae
and A. hydrophila were both isolated only from the surface of
the measuring cup that was reused continuously in ward A. All
12 S. algae isolates showed the same PFGE pattern (Figure 3)
discussion
To the best of our knowledge, no outbreak of Shewanella in-
fection in a hospital has been reported until now. In this study,
we identified some very important new findings concerning
Shewanella as an emerging pathogen in hospitals, including its
mode of transmission, its clinical manifestations, and its
pathogenicity, virulence, and infectivity. These have not been
described previously, to our knowledge.
This outbreak, which occurred in general surgery ward A,
was exceptionally unusual and unpredictable. We isolated
Shewanella species from patients’ clinical specimens in Octo-
ber 2003. When we subsequently reviewed all of the microbial
reports closely and retrospectively, we found that Shewanella
species had been isolated in June 2003. We strongly suspected
all kinds of water to be the common source of this outbreak,
especially saline solution, because of its natural properties.1,40
We closely observed any lapses in the use of aseptic technique
table 2. Multivariate Logistic Analysis (Forward
With Acquisition of Shewanella algae and Shewanell
Variable  coefficient SE
Duration of stay in ward A 0.118 0.031
Hepatobiliary disease 1.707 0.589
Constant 3.410 0.649
note. CI, confidence interval; OR, odds ratio.and infection control, in the operating room and the angiog-raphy room, where Jackson-Pratt catheters, percutaneous
catheter drainage catheters, or percutaneous transhepatic bile
drainage catheters were inserted, as well as in ward A. Interest-
ingly, no angiographic procedure was definitely identified as a
risk factor for Shewanella acquisition (Table 1). This might be
because catheters inserted in the angiography room drained
well.
All 31 case patients had external drainage catheters, which
could constitute the exact entrance of Shewanella. Of these 31
case patients, 18 (58%) had a diagnosis of hepatobiliary disease
(Tables 1 and 2). Hepatobiliary disease was confirmed by lo-
gistic analysis to be a risk factor for the acquisition of She-
wanella (OR, 5.5– 6.4; Tables 1 and 2). This finding is consis-
tent with the results of previous studies6,11,13 and might be
related to the lipophilicity of Shewanella species.41
A hospital stay in ward A showed a positive dose-response cor-
relation with the probability of Shewanella acquisition (OR, 1.1)
(Tables 1 and 2). This finding might be related to the HCW prac-
tice in ward A of draining catheters with a common cup that was
continuously reused, and this could explain why this epidemic
occurred only in ward A and not in the other general surgery
wards. Other confirmed risk factors, such time of surgery, wound
classification of “contaminated” or “dirty or infected” (OR, 16.5),
American Society of Anesthesiologists score of 3 or higher (OR,
8.0), and hospital admission via the emergency department (OR,
2.9), could illustrate the severity of host-related factors (Table 1).
pwise Conditional) Identifying Variables Associated
trefaciens
ald 2 test statistic OR (95% CI) P
14.598 1.125 (1.059–1.195) .001
8.392 5.515 (1.737–17.509) .004
27.577 0.033 .001
figure 3. Pulsed-field gel electrophoresis banding patterns of the
12 Shewanella algae isolates. Lanes 1–9, 11, and 12, isolates recovered
from blood specimens; lane 10, isolate recovered from a wound spec-Ste
a pu
W
imen. kb, kilobase; M, DNA marker.
outbreak of shewanella infections 747Interestingly, greater age (60–69 years; OR, 13.3) was a risk factor
for Shewanella acquisition for women but not for men (Table 3).
This finding is also unique because it has not been described in
previous reports.1,6,12,42
We estimated that the incubation period for Shewanella ac-
quisition ranged widely, from 3 to 49 days, based on the prob-
able day of infection with Shewanella (ie, when the drainage
catheter was inserted). We could not assess exposure times ex-
actly because we could not accurately estimate when the mea-
suring cup was changed between patients. Therefore, exposure
time could validly be considered as equivalent to the period
from drainage catheter insertion to diagnosis. Previous reports
of definite exposures to seawater or freshwater have shown
various ranges of incubation periods: 1–5 days,28 1 day,42 3
days,23,26 6 days,31 4 months,10 and 10 months.32
The medical histories of 2 possible index patients indicated
no exposure of any kind to seawater or freshwater. We could
not confirm how they originally acquired Shewanella. How-
ever, the eating of raw fish, such as sushi and other raw fish
preserved in salt, is very popular among the general population
of South Korea. Therefore, we cannot completely exclude the
possibility that these patients, or their families or visitors, in-
gested raw seafood.
In this study, the pathogenicity of the Shewanella species was
relatively high. However, we found no difference in pathoge-
nicity or virulence between S. algae and S. putrefaciens, which is
inconsistent with data from other reports.1-4,43 This discrep-
ancy might be attributable to the small number of S. putrefa-
ciens infections. Infectivity was higher for S. algae than for S.
putrefaciens, which has not been described in previous reports
(Figure 2).
Because Shewanella was recovered only from the surface of a
measuring cup used commonly for multiple patients and
PFGE patterns were identical for all isolates (Figure 3), we con-
clude that this outbreak had a single-source origin; namely, the
shared measuring cup. Only 12 isolates of S. algae recovered
from blood specimens were stored, so we were able to perform
PFGE on only some of the Shewanella isolates. The DNA frag-
ments were very small and could not be easily separated; we
tried 5 times to get the typing results (Figure 3).
After it was established that the measuring cup must be
changed after every use and that stricter infection control
methods must be implemented (including hand washing be-
fore and after patient care and use of gloves, as well as other
standard precautions), this epidemic of Shewanella infection
was brought under control. We regret that we did not detect
this unusual organism earlier.
In conclusion, we found that this outbreak had a single-
source origin, which was the shared measuring cup. She-
wanella species are more than simple environmental organ-
isms, they can act with extraordinary effectiveness as
significant opportunistic human pathogens, if they are in-
troduced into a hospital by chance. Furthermore, it cannot
be overstated that standard precautions must be strictly
maintained in hospitals.acknowledgments
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